Published works by Emily L. Hussey

Published works

• FDA Proposed Rule Establishes Criteria for Difficult Drugs to Compound Under Sections 503A and 503B

  Health Industry Washington Watch · April 2, 2024

  LEX-WK-9YCNS1HC
• FDA publishes new draft guidance on animal drug compounding

  Life Sciences Legal Update · November 25, 2019

  LEX-WK-9XMAHBY6
• FDA Partners with the National Association of Boards of Pharmacy to Create an Information-Sharing System for Drug Compounding Activities

  Life Sciences Legal Update · October 7, 2019

  LEX-WK-J0NQFA7J
• Outsourcing Facility Athenex Withdraws Appeal of District Court’s Ruling on FDA’s Placement of Bulk Drug Substances on its “Clinical Need” List

  Life Sciences Legal Update · September 27, 2019

  LEX-WK-35WZEFKH
• FDA Announces Public Hearing on Regulation of Cannabis and Cannabis-Derived Products

  Life Sciences Legal Update · April 29, 2019

  LEX-WK-KQHRP4PB
• FDA Issues 2019 Goals to Improve The Quality of Compounded Drugs

  Life Sciences Legal Update · April 9, 2019

  LEX-WK-BSF8YHN3
• FDA Announces Its Plan for Encouraging Reliance on Newer Predicate Devices and Medical Device Performance Criteria

  Life Sciences Legal Update · December 7, 2018

  LEX-WK-NPR65M6M
• FDA Withdraws “Compounding Animal Drugs from Bulk Drug Substances” Draft Guidance

  Life Sciences Legal Update · November 8, 2017

  LEX-WK-C1DV21Y5
• Recently Released Enhanced Regulatory Initiatives for Drug Compounders

  Health Industry Washington Watch · October 2, 2017

  LEX-WK-3BA0F5ZT
• The FDA Releases Enhanced Regulatory Initiatives for Drug Compounders

  Life Sciences Legal Update · October 2, 2017

  LEX-WK-JWD32JCF